Achieve Life Sciences Inc logo

Achieve Life Sciences Inc

1
NAS:ACHV (USA) Ā 
$ 3.79 +0.01 (+0.26%) 11:08 PM EST
At Loss
P/B:
4.14
Market Cap:
$ 129.99M
Enterprise V:
$ 94.18M
Volume:
71.90K
Avg Vol (2M):
130.82K
Trade In:
Volume:
71.90K
At Loss
Avg Vol (2M):
130.82K

Business Description

Description
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address theĀ smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
Name Current Vs Industry Vs History
Cash-To-Debt 4.36
Equity-to-Asset 0.66
Debt-to-Equity 0.31
Debt-to-EBITDA -0.33
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 26.99
9-Day RSI 28.02
14-Day RSI 31.54
6-1 Month Momentum % -9.3
12-1 Month Momentum % 16.89

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.78
Quick Ratio 6.78
Cash Ratio 6.39

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -51.3
Shareholder Yield % -42.49
Name Current Vs Industry Vs History
ROE % -131.03
ROA % -72.74
ROIC % -238.08
ROC (Joel Greenblatt) % -59867.06
ROCE % -93.96

Financials (Next Earnings Date:2025-03-28 Est.)

ACHV's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ACHV

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return % Ā 

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return % Ā 

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Achieve Life Sciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.11
Beta 1.94
Volatility % 51.3
14-Day RSI 31.54
14-Day ATR ($) 0.214996
20-Day SMA ($) 4.2325
12-1 Month Momentum % 16.89
52-Week Range ($) 3.6 - 5.59
Shares Outstanding (Mil) 34.39

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Achieve Life Sciences Inc Filings

Filing Date Document Date Form
No Filing Data

Achieve Life Sciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Achieve Life Sciences Inc Frequently Asked Questions

What is Achieve Life Sciences Inc(ACHV)'s stock price today?
The current price of ACHV is $3.79. The 52 week high of ACHV is $5.59 and 52 week low is $3.60.
When is next earnings date of Achieve Life Sciences Inc(ACHV)?
The next earnings date of Achieve Life Sciences Inc(ACHV) is 2025-03-28 Est..
Does Achieve Life Sciences Inc(ACHV) pay dividends? If so, how much?
Achieve Life Sciences Inc(ACHV) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1